Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
about
Drosophila neurotrophins reveal a common mechanism for nervous system formationThe antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentationIntrinsic negative cell cycle regulation provided by PIP box- and Cul4Cdt2-mediated destruction of E2f1 during S phaseAn intronic microRNA links Rb/E2F and EGFR signalingUracil-containing DNA in Drosophila: stability, stage-specific accumulation, and developmental involvementHelical Repeat Structure of Apoptosis Inhibitor 5 Reveals Protein-Protein Interaction ModulesE2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional ProgramCharacterization of human septic sera induced gene expression modulation in human myocytes.Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes.E2F and p53 induce apoptosis independently during Drosophila development but intersect in the context of DNA damage.1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cellsLoss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancerTailoring to RB: tumour suppressor status and therapeutic response.mir-11 limits the proapoptotic function of its host gene, dE2f1Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8Api5 contributes to E2F1 control of the G1/S cell cycle phase transition.Proteins and an inflammatory network expressed in colon tumors.Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.The rb pathway and cancer therapeuticsRole of the deubiquitylating enzyme DmUsp5 in coupling ubiquitin equilibrium to development and apoptosis in Drosophila melanogaster.API5 confers tumoral immune escape through FGF2-dependent cell survival pathway.Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cells.EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.Apoptosis Inhibitor 5 Increases Metastasis via Erk-mediated MMP expressionLife and death decisions by the E2F transcription factors.Long Noncoding RNA LOC100129973 Suppresses Apoptosis by Targeting miR-4707-5p and miR-4767 in Vascular Endothelial Cells.Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study.The RB/E2F pathway and regulation of RNA processingmiR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.API5 confers cancer stem cell-like properties through the FGF2-NANOG axis.Targeting AAC-11 in cancer therapy.Profiling of Host Cell Response to Successive Canine Parvovirus Infection Based on Kinetic Proteomic Change Identification.Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication.iTRAQ-based quantitative subcellular proteomic analysis of Avibirnavirus-infected cells.Biotin tagging coupled with amino acid-coded mass tagging for efficient and precise screening of interaction proteome in mammalian cellsCommon variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome.
P2860
Q21563556-E44C1445-53ED-46FE-A7D4-14376D62AA76Q24318700-0F3C27D9-8445-4B7D-8D79-1602439709A8Q24651172-0DE3ACB3-5EC5-4DD7-9F21-9EE780F4D58AQ27314824-6829EAA3-260A-45CF-B943-9F82F20E1635Q27333589-D711CE05-CA2F-4A3D-8341-9E2678DF525AQ27677281-BC57B4E5-B441-4571-B033-C1A6BA5D0C67Q28547821-EA4065A5-9702-41E2-A971-695F7F3727F7Q30487504-CE5B9115-F20E-419F-A11B-1C613A062D6FQ30492552-20DD2E66-D9B4-49D9-B7B4-8A65F3E56B1CQ33358684-20F5C888-95D3-4EC5-9E9B-CE2C262E0E18Q33687981-538E9350-8BE0-4740-B4A8-65587AFFABE2Q33977056-4FE93230-4ABD-4A5E-A010-A61C5713331FQ34017838-DA643CB6-4EFC-49B6-9454-B59DC854872FQ34040108-3724A33A-25F1-4E23-AD19-4A07EF89F9EBQ34209588-F5D7CFCD-5ADE-43DA-BFBA-3ED0E3432A02Q34625392-41B8B080-A7A8-4A32-88B6-C9C98C47597FQ34758345-8B140913-3E38-4091-AB18-D1C510C6E9E9Q34828705-6B1F9C0C-EE18-4B47-95E7-396126969B60Q34937648-0F178488-2787-44A5-B8EE-7EC4865BB1E2Q34958339-0878C6E4-3AE3-4D30-8A30-828D93D44F94Q35035220-78D16C2A-BDE7-43E0-8C26-980704A5B342Q35151449-D030C7CF-D43B-429D-AD8D-F7623FF12DC8Q35217012-5E010E7E-82EB-4A45-BFCB-41608E47D044Q35386974-BA9B5F2B-5D2B-47EE-8077-604D8FBA6975Q35448185-F7CFFA2D-FFF5-4F56-ABD7-4529E397BB7CQ35820934-A90438F1-9957-4E50-87BA-C17B6921A1F8Q36082584-0AC98D45-E272-41C4-A059-4A3ADF210C26Q36499727-388208F7-2FD2-4CF5-83C4-9E57E1270168Q36591548-C762BAFA-85C0-4FF2-977D-9A2DE80D75FFQ37368638-F5A672FB-6AC0-485F-ABC3-F6D35EF6A0D5Q37463437-4F10FABB-6ECF-4FA5-9928-9E0F05EB608FQ37597639-F478298B-F5A1-42DE-A390-147D9E1D2D60Q37627441-9B617718-E127-4540-A235-F9A1F0102121Q37650181-7FC31026-32C5-4552-B685-5D2DFC358D80Q38444908-33A6BCFD-F09F-49D0-A3EB-75F0092C6EF7Q38811471-239B7B16-B30D-4A04-87C7-33F19E788BDAQ38880484-86554EC8-E161-41CD-9594-EE8B9604DC40Q39786812-3684F447-40C4-40E7-A53D-F9D1E5956EB5Q41144757-7856A156-68B6-4135-9596-799C9EA19DEBQ41592774-E0ACC95F-D6CF-4E92-8CC8-BEA907FF4FFB
P2860
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@ast
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@en
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@en-gb
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@nl
type
label
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@ast
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@en
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@en-gb
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@nl
altLabel
Functional Identification of Api5 as a Suppressor of E2F-Dependent Apoptosis In Vivo
@en
prefLabel
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@ast
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@en
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@en-gb
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@nl
P2093
P2860
P3181
P1433
P1476
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo
@en
P2093
Erick J Morris
James W Rocco
Jun-Yuan Ji
Nam-Sung Moon
Nicholas J Dyson
William A Michaud
P2860
P3181
P356
10.1371/JOURNAL.PGEN.0020196
P407
P577
2006-11-17T00:00:00Z